Pharmaceutical Industry

Page 83 of 100

Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Top-Selling Prescription Drugs Have Seen Huge Price Hikes

By
February 2, 2016
Symbolic - biotechnology - genetic engineering
Tech

Guess What This Early Skype Investor Is Betting on Now

By
February 2, 2016
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Leadership

Gilead CEO John Martin Is Stepping Down After 20 Years

By
January 29, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Biotech Stocks Crashed and Nobody Knows Why

By
January 29, 2016
Key Speakers At The 2015 Dell World Conference
Features

New Barbie and Microsoft Earnings—5 Things to Know Today

By Tom Huddleston Jr. and Geoffrey Smith
January 28, 2016
Obama Speaks Before Leaving COP21
Leadership

You’ll Never Guess Who’s Blocking Obama’s FDA Nominee

By
January 26, 2016
Johnson & Johnson Products Ahead Of Earnings
Health

Drug Sales Are Driving Johnson & Johnson’s Growth

By
January 26, 2016
The Food and Drug Administration
Health

This Cough Syrup Was Recalled Because It Contains Morphine

By
January 22, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Martin Shkreli Is Headed For a Major Showdown With Congress

By
January 22, 2016
BRITAIN-PHARMACEUTICAL-GSK
Finance

Five Charged in U.S. With Stealing Secrets From GlaxoSmithKline

By
January 21, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health

Valeant Vows to Make Its Drugs ‘Affordable’

By
January 13, 2016
Biosimilars Are Coming After Big Pharma’s Bottom Line
Health

Biosimilars Are Coming After Big Pharma’s Bottom Line

By
January 12, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
Health

Drugmaker Shire Is Buying Baxalta for $32 Billion

By
January 11, 2016
Pfizer In Merger Talks With Allergan PLC
Health

Pfizer Just Jacked Up Prices for All of These Drugs

By
January 9, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
Health

Shire’s Merger With Baxalta Merger Is Nearly Done

By
January 8, 2016

Most Popular